TY - JOUR
T1 - The ethics of genome editing in the clinic
T2 - A dose of realism for healthcare leaders
AU - Bubela, Tania
AU - Mansour, Yael
AU - Nicol, Dianne
N1 - Publisher Copyright:
© The Canadian College of Health Leaders.
PY - 2017/5/1
Y1 - 2017/5/1
N2 - Genome editing technologies promise therapeutic advances for genetic diseases. We discuss the ethical and societal issues raised by these technologies, including their use in preclinical research, their potential to address mutations in somatic cells, and their potential to make germ line alterations that may be passed to subsequent generations. We call for a proportionate response from health leaders based on a realistic assessment of benefits, risks, and timelines for clinical translation.
AB - Genome editing technologies promise therapeutic advances for genetic diseases. We discuss the ethical and societal issues raised by these technologies, including their use in preclinical research, their potential to address mutations in somatic cells, and their potential to make germ line alterations that may be passed to subsequent generations. We call for a proportionate response from health leaders based on a realistic assessment of benefits, risks, and timelines for clinical translation.
UR - http://www.scopus.com/inward/record.url?scp=85018755802&partnerID=8YFLogxK
U2 - 10.1177/0840470416689313
DO - 10.1177/0840470416689313
M3 - Article
C2 - 28929852
AN - SCOPUS:85018755802
SN - 0840-4704
VL - 30
SP - 159
EP - 163
JO - Healthcare Management Forum
JF - Healthcare Management Forum
IS - 3
ER -
